Silicosis research awarded more than $1.6 million – Hudson Institute of Medical Research and Monash University
Date Posted – 20 May 2021 A deadly and incurable lung disease afflicting Australian tradies could be prevented from progressing and successfully treated, following a multi-million federal funding boost to silicosis research. Hudson Institute of Medical Research and…
Victorian budget invests in the health of Generation Victoria – MCRI
Date Posted – 20 May 2021 The Murdoch Children’s Research Institute (MCRI) welcomes the additional investment from the Victorian Government of $14 million AUD to support its innovative Generation Victoria (GenV) research project. The first project of its kind in Australia, GenV…
Accelagen – A 10 Year Overnight Success Story
Date Posted – 20 May 2021 Accelagen, a Melbourne based Regulatory Affairs, Clinical Research and Development Organisation, has come from humble beginnings and grown into a highly successful, effective and committed Contract Research Organisation (CRO) working with…
Federal Budget 2021 – Welcome Initiatives
Date Posted – 12 May 2021 From our CEO, Jeff Malone GAICD on the new budget… This new budget outlines a number of very welcome initiatives including continued and consistent support for the R&D tax incentive and investment into Biotech…
Snoretox wins MRFF Frontier Grant
Date Posted – 17 May 2021 The Minister for Health has announced that Snoretox has won a Medical Research Future Fund (MRFF) 2021 Frontier Health and Medical Research Initiative Grant, securing a 1 Million dollar 12 month grant and…
SA accelerates local COVID vaccine development for mutant strains
Date Posted – 13 May 2021 A leading South Australian immunologist has been awarded $3 million from the Federal Government to accelerate work on a locally developed Covid-19 vaccine, in what’s anticipated to be the second line of…
Awards Recognise Women Health Innovators
Date Posted – 13 May 2021 Four outstanding women have been recognised for their incredible work across Victoria’s health technology sector as Australia dealt with COVID-19 in 2020. Victoria’s medical and scientific communities made an important contribution to…
Imagion Biosystems and Patrys to Collaborate on Brain Tumor Imaging
Date Posted – 3 May 2021 Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, and Patrys Limited (ASX: PAB), a therapeutic antibody development company, are pleased to announce a…
New Director to Support COVID Vaccine Development at Sementis
Date Posted – 27 April 2021 Adelaide-based Australian biotechnology company Sementis has appointed internationally-renowned Dr Anna Lavelle as an Independent Director. Dr Lavelle was named among the world’s 100 most influential people in global life sciences by Scientific…
Victoria announces $50m to fund mRNA COVID-19 vaccine production in Australia, paving way for Pfizer-style manufacturing
Date Posted – 21 April 2021 The Victorian government is providing $50 million to “kickstart” domestic manufacturing of mRNA vaccine technology. It will take at least 12 months for any of the vaccines to be made in Australia,…
Mutiple Dose Part Of Ad-214 Phase I Trial Commenced – AdAlta
Date Posted – 19 April 2021 AdAlta Limited (ASX:1AD), the clinical stage biotechnology company developing novel medicines using its i-body platform is pleased to announce that the first cohort of healthy volunteers have received the first of three…
First Patients Benefit from Victoria’s Non-Invasive Gamma Knife
Date Posted – 8 April 2021 The first Gamma Knife to be installed in Victoria, at Peter MacCallum Cancer Centre, is now fully operational, with the first patients to receive the non-invasive radiosurgery sharing their experiences. The Gamma…
